Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for Divergent Trends in Chronic Myeloid Leukemia Mortality Associated with Cardiovascular Comorbidities in the United States (2018-2024): A CDC WONDER and GBD Analysis Highlighting Persistent Survivorship Risk

CML - 124

Divergent Trends in Chronic Myeloid Leukemia Mortality Associated with Cardiovascular Comorbidities in the United States (2018-2024): A CDC WONDER and GBD Analysis Highlighting Persistent Survivorship Risk

Tapan Giri

Poster Presenter: Tapan Giri

Thumbnail for DLBCL AdaptIQ: A Molecular-Adaptive Clinical Decision Support System for Personalized Regimen Selection and Real-Time Clinical Trial Matching: Development and Dataset Validation in Diffuse Large B-Cell Lymphoma

ABCL - 697

DLBCL AdaptIQ: A Molecular-Adaptive Clinical Decision Support System for Personalized Regimen Selection and Real-Time Clinical Trial Matching: Development and Dataset Validation in Diffuse Large B-Cell Lymphoma

Leena Alhusari

Poster Presenter: Leena Alhusari

Thumbnail for DNMT3A as an Epigenetic Scaffold in Acute Myeloid Leukemia: Synergistic Mutational Landscapes and Therapeutic Implications

AML - 1292

DNMT3A as an Epigenetic Scaffold in Acute Myeloid Leukemia: Synergistic Mutational Landscapes and Therapeutic Implications

Anzhela Yervandyan

Poster Presenter: Anzhela Yervandyan

Thumbnail for DNMT3A Co-Mutation and Immune Exclusion Signatures Define Outcomes in AML With IDH2 Mutations

AML - 468

DNMT3A Co-Mutation and Immune Exclusion Signatures Define Outcomes in AML With IDH2 Mutations

Feng-Ming Tien

Poster Presenter: Feng-Ming Tien

Thumbnail for Does CAR-T Therapy Overcome TP53-Driven Resistance in Lymphoma? A Systematic Review of Clinical Outcomes

CT - 126

Does CAR-T Therapy Overcome TP53-Driven Resistance in Lymphoma? A Systematic Review of Clinical Outcomes

Mostafa F Mohammed Saleh

Poster Presenter: Mostafa F Mohammed Saleh

Thumbnail for Does Minimal Residual Disease Negativity Overcome High-Risk Cytogenetics After Autologous Stem Cell Transplantation in Multiple Myeloma?

MM - 130

Does Minimal Residual Disease Negativity Overcome High-Risk Cytogenetics After Autologous Stem Cell Transplantation in Multiple Myeloma?

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Does triple trisomy (+4, +10, +17) remain prognostically significant factor in pediatric high hyperdiploid acute lymphoblastic leukemia (HD-ALL)?

ALL - 428

Does triple trisomy (+4, +10, +17) remain prognostically significant factor in pediatric high hyperdiploid acute lymphoblastic leukemia (HD-ALL)?

Elza Lomaia

Poster Presenter: Elza Lomaia

Thumbnail for Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for Indolent and Mantle Cell Lymphomas: A Systematic Review and Meta Analysis

IBCL - 004

Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for Indolent and Mantle Cell Lymphomas: A Systematic Review and Meta Analysis

Adarsh Vardhan Tangella

Poster Presenter: Adarsh Vardhan Tangella

Thumbnail for Dual Targeting of FLT3 Signaling and BCL2 Dependency by Venetoclax in ATO-Resistant FLT3-ITD Acute Promyelocytic Leukemia

AML - 424

Dual Targeting of FLT3 Signaling and BCL2 Dependency by Venetoclax in ATO-Resistant FLT3-ITD Acute Promyelocytic Leukemia

Deepshikha Dutta

Poster Presenter: Deepshikha Dutta

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.